Literature DB >> 17196748

Binding properties of Clostridium botulinum type C progenitor toxin to mucins.

Toshio Nakamura1, Noriko Takada, Takashi Tonozuka, Yoshiyuki Sakano, Keiji Oguma, Atsushi Nishikawa.   

Abstract

It has been reported that Clostridium botulinum type C 16S progenitor toxin (C16S toxin) first binds to the sialic acid on the cell surface of mucin before invading cells [A. Nishikawa, N. Uotsu, H. Arimitsu, J.C. Lee, Y. Miura, Y. Fujinaga, H. Nakada, T. Watanabe, T. Ohyama, Y. Sakano, K. Oguma, The receptor and transporter for internalization of Clostridium botulinum type C progenitor toxin into HT-29 cells, Biochem. Biophys. Res. Commun. 319 (2004) 327-333]. In this study we investigated the binding properties of the C16S toxin to glycoproteins. Although the toxin bound to membrane blotted mucin derived from the bovine submaxillary gland (BSM), which contains a lot of sialyl oligosaccharides, it did not bind to neuraminidase-treated BSM. The binding of the toxin to BSM was inhibited by N-acetylneuraminic acid, N-glycolylneuraminic acid, and sialyl oligosaccharides strongly, but was not inhibited by neutral oligosaccharides. Both sialyl alpha2-3 lactose and sialyl alpha2-6 lactose prevented binding similarly. On the other hand, the toxin also bound well to porcine gastric mucin. In this case, neutral oligosaccharides might play an important role as ligand, since galactose and lactose inhibited binding. These results suggest that the toxin is capable of recognizing a wide variety of oligosaccharide structures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17196748     DOI: 10.1016/j.bbagen.2006.11.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Crystallization and preliminary X-ray analysis of the HA3 component of Clostridium botulinum type C progenitor toxin.

Authors:  Toshio Nakamura; Takashi Tonozuka; Mao Kotani; Kanae Obata; Keiji Oguma; Atsushi Nishikawa
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-11-21

2.  Comparison of oral toxicological properties of botulinum neurotoxin serotypes A and B.

Authors:  Luisa W Cheng; Thomas D Henderson
Journal:  Toxicon       Date:  2011-05-11       Impact factor: 3.033

Review 3.  Assembly and function of the botulinum neurotoxin progenitor complex.

Authors:  Shenyan Gu; Rongsheng Jin
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

4.  Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13.

Authors:  Robert Bucki; Dorota B Namiot; Zbigniew Namiot; Paul B Savage; Paul A Janmey
Journal:  J Antimicrob Chemother       Date:  2008-05-01       Impact factor: 5.790

Review 5.  Botulinum Toxin as a Pain Killer: Players and Actions in Antinociception.

Authors:  Dong-Wan Kim; Sun-Kyung Lee; Joohong Ahnn
Journal:  Toxins (Basel)       Date:  2015-06-30       Impact factor: 4.546

6.  Functional dissection of the Clostridium botulinum type B hemagglutinin complex: identification of the carbohydrate and E-cadherin binding sites.

Authors:  Yo Sugawara; Masahiro Yutani; Sho Amatsu; Takuhiro Matsumura; Yukako Fujinaga
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

7.  Glycan detecting tools developed from the Clostridium botulinum whole hemagglutinin complex.

Authors:  Ea Kristine Clarisse Tulin; Chiaki Nakazawa; Tomomi Nakamura; Shion Saito; Naoki Ohzono; Keiko Hiemori; Shin-Ichi Nakakita; Hiroaki Tateno; Takashi Tonozuka; Atsushi Nishikawa
Journal:  Sci Rep       Date:  2021-11-09       Impact factor: 4.379

8.  Botulinum neurotoxin A complex recognizes host carbohydrates through its hemagglutinin component.

Authors:  Guorui Yao; Kwangkook Lee; Shenyan Gu; Kwok-Ho Lam; Rongsheng Jin
Journal:  Toxins (Basel)       Date:  2014-02-12       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.